NCT00697151View on ClinicalTrials.gov

Patent Foramen Ovale in Cryptogenic Stroke Study

PHASE4CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

June 30, 1993

Primary Completion Date

June 30, 2000

Study Completion Date

June 30, 2000

Conditions
Ischemic StrokePatent Foramen Ovale
Interventions
DRUG

Warfarin

Warfarin once a day, titrated to obtain an INR of 1.4 to 2.8; placebo aspirin once a day

DRUG

Aspirin

Aspirin 325 mg once a day; placebo warfarin once a day

Trial Locations (1)

10032

Columbia College of Physicians and Surgeons, New York

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Columbia University

OTHER

NCT00697151 - Patent Foramen Ovale in Cryptogenic Stroke Study | Biotech Hunter | Biotech Hunter